In what’s believed to be one of the largest population-based studies of Oncotype DX ever conducted, researchers at The University of Texas MD Anderson Cancer Center have found that the commercial diagnostic tool, Oncotype DX, was associated with a decrease in chemotherapy use in younger p…
Source:Oncotype DX assay linked to decrease in chemotherapy use in younger patients
Sunday, December 14, 2014
Oncotype DX assay linked to decrease in chemotherapy use in younger patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment